Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Butanilicaine is a small molecule local anesthetic of the amide type. It acts primarily by blocking voltage-gated sodium channels in nerve fibers, thereby inhibiting nerve conduction and preventing the propagation of action potentials. This mechanism results in reversible local anesthesia without permanent damage to nerve tissues. In addition to its anesthetic properties, butanilicaine exhibits vasodilator effects and has been reported to have a low incidence of systemic toxicity and allergic reactions compared to some other local anesthetics. Its efficacy is comparable to agents like lidocaine and bupivacaine[1][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Butanilicaine.